873436-53-4

Upstream product

• 144-62-7 oxalic acid 
• 100306-34-1 3-chloro-1-phenylpropanol 
• 124-40-3 dimethyl amine 
• 36296-97-6 (S)-3-(dimethylamino)-1-phenylpropan-1-ol 

Downstream Products

• 36296-97-6 (S)-3-(dimethylamino)-1-phenylpropan-1-ol 
• 1270016-47-1 (R)-N,N-dimetyl-3-(2-methyl-(4-acetylphenyl)oxy)-3-phenyl-1-aminopropane oxalate 
• 1270016-49-3 (R)-N,N-dimethyl-3-(2-methyl-(4-acetoxyphenyl)oxy)-3-phenyl-1-aminopropane 
• 1270016-51-7 C₂₆H₂₇NO₅ 
• 457634-24-1 R-(-)-N-methyl-3-(2-methyl-4-hydroxyphenyloxy)-3-phenyl-1-aminopropane hydrochloride 

Relevant academic research and scientific papers

AMIDO THIADIAZOLE DERIVATIVES AS NADPH OXIDASE INHIBITORS

The present invention is related to amino thiazole derivatives of Formula (I), pharmaceutical composition thereof and to their use for the treatment and/or prophylaxis of disorders or conditions related to Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase).

NOVEL PROCESS FOR THE PREPARATION OF 4-HYDROXY ATOMOXETINE

The present invention relates to novel process for the preparation of 4-hydroxy Atomoxetine or its pharmaceutically acceptable salts thereof. The present invention also relates to novel intermediates used in the preparation of 4-hydroxy Atomoxetine.

Process for manufacturing of enantiomerically pure 3-hydroxy-3-phenyl-propylamin

The present invention relates to an improved process for preparing enantiomerically pure 3-hydroxy-3-phenyl-propylamines on an industrial scale using asymmetrical hydrogenation as a key step and optionally a special sequence of subsequent steps, using a catalyst system consisting of rhodium and chiral 4-(dicyclohexylphosphino)-2-(diphenyl-phosphino-methyl)-N-methyl-aminocarbonyl-pyrrolidine.